新产业：公司肌红蛋白测定试剂盒获得医疗器械注册证

Core Viewpoint - The company has received a medical device registration certificate for its myoglobin assay kit, which is intended for the quantitative measurement of myoglobin levels in human serum or plasma, aiding in the diagnosis of myocardial infarction [1] Group 1: Product Development - The myoglobin assay kit utilizes a latex immunoturbidimetric method [1] - The approval from the Guangdong Provincial Drug Administration enhances the company's portfolio in the "cardiovascular and myocardial markers" category of biochemical testing products [1] Group 2: Impact on Business - The introduction of this new product is expected to have a positive impact on the company's development [1] - However, it will not significantly affect the company's recent production operations and performance [1]